IV NAD+ Therapy for Autoimmune Diseases
Innovative approaches are changing how we treat autoimmune conditions. NAD+ IV therapy represents a promising frontier in addressing these complex disorders.
Ramesh Kumar, MD
561-210-9999
Understanding Autoimmune Diseases
24M
Americans Affected
Up to 8% of US population lives with autoimmune conditions
80+
Known Disorders
Including lupus, MS, and rheumatoid arthritis
75%
Female Patients
Women are disproportionately affected by these conditions
What Is NAD+?

Cellular Energy
Powers metabolic processes
DNA Repair
Supports genetic integrity
Cell Protection
Defends against oxidative stress
NAD+ (nicotinamide adenine dinucleotide) is a vital coenzyme found in every cell. Levels naturally decline with age and chronic illness.
NAD+ IV Therapy: The Concept
Direct Infusion
NAD+ delivered intravenously
Maximum Absorption
Bypasses digestive system
Cellular Uptake
Replenishes depleted NAD+ levels
Mechanisms: How NAD+ Impacts Autoimmunity
1
1
Immune Modulation
Regulates T cells, B cells, and macrophage activity
Inflammation Reduction
Decreases pro-inflammatory cytokines
Tissue Recovery
Enhances DNA repair mechanisms
Energy Production
Improves mitochondrial function
Research and Evidence
1
Preclinical Studies
NAD+ reduced inflammation in animal models of MS
2
Case Reports
Anecdotal evidence shows symptom relief in patients
3
Ongoing Research
Clinical trials evaluating efficacy and optimal protocols
4
Future Directions
Combination therapies being explored
Safety, Tolerability, and Clinical Practice
Common Side Effects
  • Temporary flushing
  • Mild nausea
  • Headache
Administration
  • Licensed medical professionals
  • Sterile clinical environment
  • Personalized dosing protocols
Regulatory Status
  • Not FDA-approved for treatment
  • Used as complementary therapy
  • Research ongoing
Conclusion & Future Outlook
Current Promise
NAD+ IV therapy shows potential for symptom management and immune modulation in autoimmune patients.
Research Needs
More clinical trials required to confirm efficacy, establish protocols, and understand long-term effects.
Future Integration
May become part of comprehensive treatment plans alongside conventional therapies.
Ramesh Kumar, MD
561-210-9999